World Coalition on Adult Vaccination

–

World Coalition on Adult Vaccination

About the coalition

Vaccination is one of the most successful public health practices in history and is considered a pivotal advancement in modern medicine. Older adults and those with chronic medical conditions are a rapidly growing global population at high risk of life-altering complications from vaccine-preventable diseases (VPDs).

Vaccines are critical to the prevention and control of many VPDs, across all ages, and therefore underpin global health security. Immunisation throughout the life course is an effective public health intervention, that not only contributes to maintaining and improving population health across all ages but reduces the burden on healthcare professionals and systems.

Vaccine4Life (V4L), through the World Coalition on Adult Vaccination, calls on all champions and advocates representing constituents in the fields of health, ageing, chronic disease, public health, social justice, and inter-generational solidarity, among many others, to embrace the narrative of a life course approach to vaccination.

Learn more

Members

The World Coalition on Adult Vaccination is made up of non-governmental organizations and academia, clinicians, public health and scientific experts and associations worldwide collaborating on a common agenda around a life course approach to vaccination, with special attention to later life.

Purpose

Through the coalition, the purpose is to mobilize experts and their networks to help influence and shape policies to improve the uptake rates of adult vaccinations through prioritizing prevention, improving access, and reducing inequity.

Learn more

Join the coalition

Interested in joining the Coalition? Please apply to join the Coalition by clicking “Learn More” and completing the submission form.

Learn more

Pneumonia Vaccination in LTC settings in Canada Banner

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.

The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.

Download the Technical report

27 April 2023, Toronto, ON – The International Federation on Ageing (IFA) is proud to release findings from a recent study entitled Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care. Check out the technical report to learn more.